Smoking activates cytotoxic CD8+ T cells and causes survivin release in rheumatoid arthritis

J Autoimmun. 2017 Mar:78:101-110. doi: 10.1016/j.jaut.2016.12.009. Epub 2017 Jan 9.

Abstract

CD8+ T cells have an emerging role in RA. Resent research indicates a causal relationship between the non-exhausted state of CD8+ T cells, defined by lost function of PD-1, and development of arthritis. We investigated how smoking contributes to the non-exhausted phenotype of CD8+ T cells and cause survivin release to serum. We compared serum survivin levels between smokers and non-smokers in 252 RA and 168 healthy subjects. Nicotine effects on CD8+ T cells were studied in peripheral blood of smoking women, bone marrow of nicotine treated mice and in sorted CD8 spleen cells in vitro using flow cytometry and quantitative PCR. Smoking increased the frequency of survivin release in serum of healthy women (OR 3.64, p = 0.025) and in RA patients (OR 1.98, p = 0.039). CD8+ T cells of smokers gained a non-exhausted PD-1 deficient phenotype. Expression of the cytotoxic marker CD107 correlated to survivin levels in serum. In the experimental setting, nicotine exposure led to an accumulation of non-exhausted PD-1-IL-7R+ CD8+ T cells in the bone marrow that is abundant with survivin producing cells. The production of the cytolytic protein perforin in bone marrow correlated to serum survivin levels. In vitro stimulation of nicotinic receptors on murine CD8+ T cells induced repressive transcription factors T-bet and Blimp-1 in support of the non-exhausted phenotype. We conclude that nicotine contributes to autoimmunity by supporting the non-exhausted state of CD8+ T cells resulting in the release of survivin. This presents a new mechanism by which smoking may contribute to the pathogenesis of RA.

Keywords: CD8(+) T cells; Interleukin-7 receptor; Programmed cell death 1; Rheumatoid arthritis; Smoking; Survivin.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Arthritis, Rheumatoid / genetics
  • Arthritis, Rheumatoid / immunology*
  • Arthritis, Rheumatoid / metabolism*
  • Biomarkers
  • Bone Marrow / drug effects
  • Bone Marrow / metabolism
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Disease Models, Animal
  • Female
  • Humans
  • Immunophenotyping
  • Inhibitor of Apoptosis Proteins / biosynthesis*
  • Inhibitor of Apoptosis Proteins / blood
  • Lymphocyte Activation / genetics
  • Lymphocyte Activation / immunology*
  • Male
  • Mice
  • Mice, Knockout
  • Middle Aged
  • Nicotine / pharmacology
  • Phenotype
  • Programmed Cell Death 1 Receptor / deficiency
  • Programmed Cell Death 1 Receptor / metabolism
  • Smoking*
  • Survivin
  • T-Lymphocytes, Cytotoxic / drug effects
  • T-Lymphocytes, Cytotoxic / immunology*
  • T-Lymphocytes, Cytotoxic / metabolism*
  • Young Adult

Substances

  • BIRC5 protein, human
  • Biomarkers
  • Inhibitor of Apoptosis Proteins
  • Programmed Cell Death 1 Receptor
  • Survivin
  • Nicotine